CIENCIASMEDICASNEWS: Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease - The Lancet Respiratory Medicine

domingo, 18 de julio de 2021

Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease - The Lancet Respiratory Medicine

Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease - The Lancet Respiratory Medicine

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)